Health And Medicine
-
Study finds sharp rise in suicide risk for children
The number of school-age children and adolescents hospitalized for suicidal thoughts or attempts has more than doubled since 2008, according to a new Vanderbilt-led study published in Pediatrics. Read MoreMay 17, 2018
-
Early discharge of NAS infants prolongs treatment
Infants who are diagnosed with drug withdrawal after birth who are treated with medication as outpatients at home are treated three times longer than infants treated solely as inpatients, according to a new Vanderbilt study. Read MoreMay 17, 2018
-
VU BreakThru: TIPs grant funds innovative research into the microbiome
Right under your nose but unseen by the human eye is the microbiome—the totality of microbes in an environment. The Vanderbilt Microbiome Initiative, funded by a TIPs grant, is coordinating basic, translational and clinical scholarship to help unlock the mysteries of these bacteria, viruses and more. Learn about the initiative and its new website in this VU BreakThru blog post. Read more about TIPs grants and other internal faculty funding programs—including University Courses, Research Scholar Grants and Discovery Grants—at the VU BreakThru blog. Read MoreMay 15, 2018
-
Study finds acetaminophen helps reduce acute kidney injury risk in children following cardiac surgery
Children who underwent cardiac surgery were less likely to develop acute kidney injury if they had been treated with acetaminophen in the first 48 hours after their procedures, according to a Vanderbilt study just published in JAMA Pediatrics. Read MoreMay 14, 2018
-
Grant bolsters kidney cancer immunotherapy research
W. Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer. Read MoreMay 10, 2018
-
Study finds generic options offer limited savings for expensive drugs
Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released this week. Read MoreMay 9, 2018
-
Putting the brakes on sepsis
An enzyme called PTEN reduces inflammatory signaling and mortality in sepsis, suggesting it may be a good therapeutic target for this life-threatening complication of infection. Read MoreMay 9, 2018
-
Records point to drug-drug interaction
Patients who take a cholesterol-lowering statin drug while taking the antibiotic daptomycin have increased risk of developing muscle weakness or a more severe form of muscle damage. Read MoreMay 7, 2018
-
New breast cancer targets
A special genetic analysis has revealed candidate genes associated with increased risk of breast cancer. Read MoreMay 4, 2018
-
Understanding HDL structure
Structural features of newly formed HDL particles will help guide understanding of “good cholesterol” and its function. Read MoreMay 3, 2018
-
Gene study spots clues to heart risk for statin patients
A Vanderbilt-led research team has discovered genetic variations that increase the risk of heart attack even when patients are receiving a statin drug like Lipitor or Crestor to lower their blood cholesterol. Read MoreMay 3, 2018
-
New report shows prevalence of autism rising in U.S.
The prevalence of U.S. children with autism spectrum disorder (ASD) is now 1 in 59, according to new estimates released Thursday by the Centers for Disease Control and Prevention (CDC), a significant increase from the 1 in 68 estimate in 2016. Read MoreApr 26, 2018
-
Study seeking to isolate antibodies against rabies virus
Few people die from rabid animal bites in the United States thanks to the near-universal availability of human rabies immune globulin and rabies vaccine, which are given as separate shots as soon as possible after exposure to the rabies virus. Read MoreApr 26, 2018
-
Gene expression in mitral valve disease
A protease gene family may be new targets for treating mitral valve disease, which causes blood to flow backwards in the heart. Read MoreApr 25, 2018
-
Toxin floats on lipid rafts
The bacterium H. pylori is a leading cause of stomach cancer, and Vanderbilt researchers are studying how one of its toxins gets into cells. Read MoreApr 23, 2018
-
Ancora inaugural request for proposals announced
The Office of the Vice Provost for Research and Deerfield Management announce the inaugural request for proposals for Ancora Innovation, LLC, with a due date of June 4. An RFP information session is scheduled from 2 to 3:30 p.m. Friday, April 27, at Sarratt Student Center, Room 325. Read MoreApr 20, 2018
-
Disease-fighting antibody production
New research links nutrient-responsive cellular signaling to the antibody-mediated immune response. Read MoreApr 20, 2018
-
How the skin protects
Treatments for common skin conditions such as atopic dermatitis may be improved by understanding the enzymes responsible for forming the skin’s water-tight barrier. Read MoreApr 19, 2018
-
MRI technique detects spinal cord changes in MS patients: study
A Vanderbilt University Medical Center-led research team has shown that magnetic resonance imaging (MRI) can detect changes in resting-state spinal cord function in patients with multiple sclerosis (MS). Read MoreApr 19, 2018
-
Characterizing ‘keyhole’ is first step to fighting obesity at the cellular level
A Vanderbilt team and their international colleagues characterized for the first time a complex, little-understood cellular receptor type that, when activated, shuts off hunger. Read MoreApr 18, 2018